Serial Number 88025150
606

Registration Progress

Application Filed
Jul 3, 2018
Under Examination
Feb 4, 2020
Approved for Publication
Dec 10, 2019
Published for Opposition
Dec 10, 2019
Registered

Trademark Image

Basic Information

Serial Number
88025150
Filing Date
July 3, 2018
Published for Opposition
December 10, 2019
Abandonment Date
September 7, 2020
Drawing Code
2000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Sep 7, 2020
Classes
005

Rights Holder

Madrona Pharmaceuticals

03
Address
P.O. Box 99162
Seattle, WA 981390162

Ownership History

Madrona Pharmaceuticals

Original Applicant
03
Seattle, WA

Madrona Pharmaceuticals

Owner at Publication
03
Seattle, WA

Legal Representation

Attorney
Matthew Moersfelder

USPTO Deadlines

All Deadlines Cleared

All 6 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

26 events
Date Code Type Description Documents
Sep 8, 2020 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Sep 7, 2020 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Feb 4, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Dec 10, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 10, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 20, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 4, 2019 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Nov 1, 2019 ALIE A ASSIGNED TO LIE Loading...
Oct 28, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 25, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 24, 2019 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Oct 24, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 24, 2019 CNFR R FINAL REFUSAL WRITTEN Loading...
Apr 24, 2019 GNFR O FINAL REFUSAL E-MAILED Loading...
Apr 24, 2019 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Apr 23, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 22, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Apr 22, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 18, 2018 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Oct 23, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 23, 2018 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 23, 2018 GNRT F NON-FINAL ACTION E-MAILED Loading...
Oct 23, 2018 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jul 11, 2018 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Jul 10, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 6, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical preparations for treatment of pain, allergies, insomnia, heartburn, high-blood pressure, coughing, fever, colds, diarrhea, constipation, all of the foregoing using dosage forms to make medicines easier to take, manage and monitor; pharmaceutical preparations, namely, unit does capsules sold empty using dosage forms to make medicines easier to take, manage and monitor; pharmaceutical preparations for the treatment of infectious diseases caused by Bacillus anthracis, Bacillus cereus, Bartonella henselae, Bartonella Quintana, Bordetella pertussis, Borrelia burgdorferi, Borrelia garinii, Borrelia afzelii, Borrelia recurrentis, Brucella abortus, Brucella canis, Brucella melitensis, Brucella suis, Campylobacter jejuni, Chlamydia pneumoniae, Chlamydia trachomatis, Chlamydophila psittaci, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Clostridium tetani, Corynebacterium diphtheriae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Francisella tularensis, Haemophilus influenzae, Helicobacter pylori, Legionella pneumophila, Leptospira interrogans, Leptospira santarosai, Leptospira weilii, Leptospira noguchii, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Mycobacterium ulcerans, Mycoplasma pneumoniae, Neisseria gonorrhoeae, Neisseria meningitidis, Pseudomonas aeruginosa, Rickettsia rickettsia, Salmonella typhimurium, Shigella sonnei, Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus saprophyticus, Streptococcus agalactiae, Streptococcus pneumoniae, Streptococcus pyogenes, Treponema pallidum, Ureaplasma urealyticum, Vibrio cholerae, Yersinia pestis, Yersinia enterocolitica, or Yersinia pseudotuberculosis using dosage forms to make medicines easier to take, manage and monitor
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Design Mark
The mark consists of a tree design consisting of a black oval atop a black base sitting on a wavy line.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005